ALBUNORM

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Poland, Romania, Singapore, Tunisia, United Kingdom

Active ingredients

The drug ALBUNORM contains one active pharmaceutical ingredient (API):

1 Albumin
UNII ZIF514RVZR - ALBUMIN HUMAN

Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.

Read about Albumin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ALBUNORM Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B05AA01 Albumin B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1347049, 1347050, 1347061, 1347072, 1347083, 1347094, 1347106, 1347117, 1347128, 1439962, 1439973, 1439984, 1439995, 1440098, 1440111
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 70738, 70739
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 054343, 054376, 094554
Country: FR Base de données publique des médicaments Identifier(s): 66967127, 67960160, 69227858
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 172269, 172271, 172273, 172275, 353788
Country: HK Department of Health Drug Office Identifier(s): 67180, 67181
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7721, 7722, 7723
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1032078, 1032079, 1037663, 1037664, 1037665, 1037666, 1037667, 1037668, 1037669
Country: MT Medicines Authority Identifier(s): MA1219/00301, MA1219/00302, MA1219/00303, MA1219/00304, MA1219/00305
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100215068, 100215111
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65345001, W65345002, W65345003, W65345004, W65345005, W65346001, W65346002, W65346003, W65346004, W65347001, W65347002
Country: SG Health Sciences Authority Identifier(s): 15159P, 15160P, 15161P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 10043011H

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.